Showing 1 - 15 results of 15 for search 'Epilepsy Society', query time: 0.06s Refine Results
  1. 1

    Assessment of stigmatization in people with epilepsy by G. Pociuvienė, D. Streckytė, R. Mameniškienė

    Published 2020-09-01
    “…Although 93.8% of PWE have heard/read about epilepsy (p=0.137), 24.8% of them believe that epilepsy is a mental illness (p=0.723); 66.7% think that epilepsy is incurable (p=0.798); 45% reported that society treats PWE differently (more often women, p=0.028), and 63.6% think that PWE face difficulties working and studying (p=0.485). …”
    Get full text
    Article
  2. 2
  3. 3

    Etiopathogenic theories of nervous system diseases in Vilnius in the early 19th century: “insanity and epilepsy exacerbate when the moonlight shines” by E. Sakalauskaitė-Juodeikienė

    Published 2023-10-01
    “…First, we analysed old doctoral dissertations on NS diseases defended at VU in 1803-1832; we then turned to Consessus Caesareae Societatis Medicae Vilnensis (The Protocols of Vilnius Medical Society) and analysed clinical reports recorded in 1806-1842. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    FREQUENCY OF DEPRESSION AND ANXIETY AMONGADULT EPILEPTIC PATIENTS by Monica Vaswani

    Published 2024-10-01
    “…Similar to depression, it has also been found to be of moderate severity i.e. 83/171 (48.5%). In a stigmatized society like Pakistan, living with epilepsy is a problem. …”
    Get full text
    Article
  10. 10

    New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor by K. Ryliškienė, D. Jatužis, A. Vaitkus

    Published 2019-12-01
    “… Migraine is a long-lasting neurological disorder with significant negative impact not only on the patient’s life, but also on society. For many years, preventive treatment of migraine included drugs developed for diseases other than migraine such as hypertension, depression, and epilepsy. …”
    Get full text
    Article
  11. 11

    Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry by Tamas Bartfai, Graham Vaughan Lees

    Published 2011-01-01
    “…The programs are deemed to be too risky and not lucrative enough for Big Pharma in the current climate. Society has a real need for the drugs that are no longer going to be developed for, among others, drug-resistant epilepsy, neuropathic and cancer pain, type-2 diabetes, obesity, and schizophrenia. …”
    Get full text
    Article
  12. 12
  13. 13

    Neuromodulation: clinical advances and future perspectives by ZHANG Jian⁃guo, XIE Hu⁃tao, YANG An⁃chao

    Published 2025-01-01
    “…With the rapid development of society and economy and the acceleration of population aging, the global disease spectrum has undergone profound changes. …”
    Get full text
    Article
  14. 14
  15. 15